Creative Planning
- SEC CIK
- 0001540235
- Latest filing
- Aug 13, 2026
MDGL holding history
Madrigal Pharmaceuticals, Inc. in every 13F filed by Creative Planning, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MDGL overviewAll 13F holders of MDGLFull Q2 2026 holdings
- Shares (Q2 2026)
- 13,147
- Value
- $7.06M
- % of portfolio
- <0.1%
- Quarters held
- 12
- Since Q3 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 13,147 | $7.06M | <0.1% | +1,142+9.5% | Added | Holders |
| Q1 2026 | 12,005 | $6.28M | <0.1% | +864+7.8% | Added | Holders |
| Q4 2025 | 11,141 | $6.49M | <0.1% | +2,711+32.2% | Added | Holders |
| Q3 2025 | 8,430 | $3.87M | <0.1% | +3,268+63.3% | Added | Holders |
| Q2 2025 | 5,162 | $1.56M | <0.1% | −2,202−29.9% | Reduced | Holders |
| Q1 2025 | 7,364 | $2.44M | <0.1% | +2,933+66.2% | Added | Holders |
| Q4 2024 | 4,431 | $1.37M | <0.1% | +1,132+34.3% | Added | Holders |
| Q3 2024 | 3,299 | $700.1K | <0.1% | +87+2.7% | Added | Holders |
| Q2 2024 | 3,212 | $899.8K | <0.1% | +935+41.1% | Added | Holders |
| Q1 2024 | 2,277 | $608.0K | <0.1% | +419+22.6% | Added | Holders |
| Q4 2023 | 1,858 | $429.9K | <0.1% | −216−10.4% | Reduced | Holders |
| Q3 2023 | 2,074 | $302.9K | <0.1% | +2,074 | New | Holders |